Capitol Health (ASX:CAJ) - Cotización, noticias y análisis

Resumen de acción CAJ

Capitol Health Limited ofrece modalidades de diagnóstico por imagen y servicios afines al mercado sanitario de Australia.

Acerca de la empresa

CAJ fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	2/6
Financial Health	1/6
Dividends	2/6

Recompensas

Cotiza un 18.2% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 38.69%

Ha pasado a ser rentable este año

Análisis de riesgos

Los pagos de intereses no están bien cubiertos por los beneficios

El dividendo de 4.17% no está bien cubierto por beneficios o flujos de caja

Grandes partidas extraordinarias que afectan a los resultados financieros

Competidores de Capitol Health Limited

Healthia

ASX:HLA

AU$252.1m

Australian Clinical Labs

ASX:ACL

AU$493.2m

SILK Laser Australia

ASX:SLA

AU$177.4m

Apiam Animal Health

ASX:AHX

AU$72.6m

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Capitol Health
Historical stock prices
Current Share Price	AU$0.24
52 Week High	AU$0.30
52 Week Low	AU$0.18
Beta	0.68
1 Month Change	0%
3 Month Change	-2.04%
1 Year Change	-12.73%
3 Year Change	-36.00%
5 Year Change	-7.69%
Change since IPO	-9.43%

Noticias y actualizaciones recientes

Recent updates

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 05

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Feb 14

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Jan 19

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Dec 22

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Dec 01

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Aug 17

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Jul 25

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Jul 04

Rentabilidad de los accionistas

	CAJ	AU Healthcare	Mercado AU
7D	4.3%	1.3%	0.03%
1Y	-12.7%	-21.6%	4.2%

Rentabilidad vs. Industria: CAJ superó al sector Australian Healthcare , que obtuvo un rendimiento del -20.9% el año pasado.

Rentabilidad vs. Mercado: CAJ obtuvo unos resultados inferiores a los del mercado Australian, que fue del 5.7% el año pasado.

Volatilidad de los precios

Is CAJ's price volatile compared to industry and market?
CAJ volatility
CAJ Average Weekly Movement	6.1%
Healthcare Industry Average Movement	6.8%
Market Average Movement	9.0%
10% most volatile stocks in AU Market	17.7%
10% least volatile stocks in AU Market	3.5%

Precio estable de las acciones: CAJ no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de CAJ (6%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
2005	1,000	Justin Walter	www.capitolhealth.com.au

Capitol Health Limited ofrece modalidades de diagnóstico por imagen y servicios relacionados al mercado sanitario en Australia. Ofrece diversos servicios de diagnóstico por imagen, como radiografía general, resonancia magnética, ecografía, mamografía, Doppler, ortopantomografía, ecocardiografía, tomografía computarizada, angiografía por TC, TC de haz cónico, medicina nuclear, densitometría ósea y fluoroscopia. Explotaba varias clínicas en Victoria, Tasmania, Australia Occidental y Australia Meridional bajo la marca Capital Radiology, así como bajo las marcas Imaging Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Womens' Imaging, Direct Radiology y Future Medical Imaging Group.

Resumen de fundamentos de Capitol Health Limited

¿Cómo se comparan los beneficios e ingresos de Capitol Health con su capitalización de mercado?
Estadísticas fundamentales de CAJ
Capitalización bursátil	AU$255.70m
Beneficios(TTM)	AU$6.14m
Ingresos (TTM)	AU$229.29m

41.6x

Ratio precio-beneficio (PE)

1.1x

Ratio precio-ventas (PS)

¿Está CAJ sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de CAJ
Ingresos	AU$229.29m
Coste de los ingresos	AU$178.18m
Beneficio bruto	AU$51.11m
Otros gastos	AU$44.97m
Beneficios	AU$6.14m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)	0.0058
Margen bruto	22.29%
Margen de beneficio neto	2.68%
Ratio deuda/patrimonio	62.0%

¿Cómo se ha desempeñado CAJ a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

4.2%

Rentabilidad actual por dividendo

173%

Ratio de pagos

Resumen de acción CAJ

Recompensas

Análisis de riesgos

Competidores de Capitol Health Limited

ASX:HLA

AU$252.1m

ASX:ACL

AU$493.2m

ASX:SLA

AU$177.4m

ASX:AHX

AU$72.6m

Historial de precios y rendimiento

Noticias y actualizaciones recientes

Now 21% undervalued after recent price drop

Now 21% undervalued

First half dividend of AU$0.005 announced

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

New major risk - Financial position

Now 20% undervalued

Recent updates

Now 21% undervalued after recent price drop

Now 21% undervalued

First half dividend of AU$0.005 announced

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

New major risk - Financial position

Now 20% undervalued

Capitol Health Limited to Report First Half, 2024 Results on Feb 29, 2024

Capitol Health Limited Appoints Brendon Pentland as the Chief Financial Officer, Effective 1 April 2024

Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Now 21% undervalued

Now 21% undervalued after recent price drop

Capitol Health Limited Announces the Resignation of Craig Bremner as Chief Financial Officer

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased by 9.8% to AU$0.28

Capitol Health Limited, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings: EPS misses analyst expectations

Capitol Health Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Price target decreased by 9.6% to AU$0.33

Capitol Health Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued

Now 21% undervalued

Capitol Health Limited (ASX:CAJ) completed the acquisition of Future Medical Imaging Group Pty Ltd.

Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Capitol Health Limited Declares Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Price target increased to AU$0.43

Capitol Health Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings: EPS misses analyst expectations

Capitol Health Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 October, 2022

Consensus EPS estimates fall by 12%

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Capitol Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 1, 2022

Capitol Health Limited to Report First Half, 2022 Results on Feb 24, 2022

Full year 2021 earnings released: EPS AU$0.012 (vs AU$0.001 in FY 2020)

Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Analysts increase EPS estimates to AU$0.012

First half 2021 earnings released: EPS AU$0.006 (vs AU$0.004 in 1H 2020)

Price target raised to AU$0.36

New 90-day high: AU$0.34

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Capitol Health Limited (ASX:CAJ) acquired Direct Radiology.

Capitol Health Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$0.28

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Price target raised to AU$0.31

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

New 90-day high: AU$0.27

Capitol Health Limited Appoints Craig Bremner as Chief Financial Officer, November 9, 2020

Capitol Health Limited Announces Resignation of Marcell Judkins as Chief Financial Officer

Price target raised to AU$0.27

Capitol Health Limited (ASX:CAJ) completed the acquisition of 90% stake in Fowler Simmons Radiology.

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Capitol Health Limited to Report Fiscal Year 2020 Results on Aug 26, 2020